Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma
Glioblastoma (GBM) microenvironment heterogeneity poses a major challenge to GBM therapy. Glioma stem cells (GSCs) and tumor-associated macrophages (TAMs) are important elements in the GBM microenvironment and are crucial for malignant progression. Here, we constructed prodrug nanoparticles (A-PER-p(TMZ)/Clo) containing perifosine (Akt inhibitors), an ester bond-linked poly-temozolomide (poly(TMZ)) prodrug, and clodronate (Clo) for combined approach to TAMs depletion, GSCs eradication, and activation inhibition of GBM. A-PER-p(TMZ)/Clo treatment in a mouse model of intracranial GBM significantly inhibited tumor growth and markedly extended survival. These findings suggest that A-PER-p(TMZ)/Clo provides a new strategy for therapeutic targeting of the heterogeneous glioma microenvironment.
Booz Allen Foundation;Booz Allen Foundation[2020BS117];Booz Allen Foundation;Booz Allen Foundation;
|WOS Research Area|
Engineering, Environmental ; Engineering, Chemical
|WOS Accession No|
|ESI Research Field|
Cited Times [WOS]:0
|Document Type||Journal Article|
|Department||Department of Biomedical Engineering|
1.Department of Biomedical Engineering,Southern University of Science and Technology,Shenzhen,No. 1088, Xueyuan Avenue,518055,China
2.Institute of Nervous System Diseases,Xuzhou Medical University,Xuzhou,No. 84 Huaihai Xi Road,221002,China
3.Department of Neurosurgery,Shengjing Hospital of China Medical University,Shenyang,No. 36, Sanhao Street, Heping District, Liaoning,110004,China
4.Department of Neurosurgery,The First Hospital of China Medical University,Shenyang,No. 155, Nanjing Bei Street,110001,China
5.Department of Neurosurgery,Affiliated Huaian Hospital of Xuzhou Medical University,No. 62, Huaihai Bei Road,223002,China
|First Author Affilication||Department of Biomedical Engineering|
|First Author's First Affilication||Department of Biomedical Engineering|
Zhang，Xuefeng,Guo，Qing,Zhao，Zongren,et al. Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma[J]. Chemical Engineering Journal,2023,474.
Zhang，Xuefeng,Guo，Qing,Zhao，Zongren,Cheng，Peng,Wu，Anhua,&Liu，Hongmei.(2023).Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma.Chemical Engineering Journal,474.
Zhang，Xuefeng,et al."Engineering prodrug nanoparticles for targeted therapy in heterogeneous glioblastoma".Chemical Engineering Journal 474(2023).
|Files in This Item:||There are no files associated with this item.|
|Recommend this item|
|Export to Endnote|
|Export to Excel|
|Export to Csv|
|Similar articles in Google Scholar|
|Similar articles in Baidu Scholar|
|Similar articles in Bing Scholar|
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.